Exact Mass: 492.2089
Exact Mass Matches: 492.2089
Found 500 metabolites which its exact mass value is equals to given mass value 492.2089
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Isolariciresinol 9'-O-alpha-L-arabinofuranoside
Isolariciresinol 9-O-alpha-L-arabinofuranoside is a constituent of Scots pine (Pinus sylvestris) needles. Constituent of Scots pine (Pinus sylvestris) needles.
4-[2-[2-[3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoic acid
3-[2-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]propanoylamino]-4-oxobutanoic acid
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
Cilnidipine
2-[4-[2-[(2,4-Difluorophenyl)carbamoyl-heptylamino]ethyl]phenyl]sulfanyl-2-methylpropanoic acid
Ile-Glu-Thr-Asp-fluoromethyl ketone
Loperamide oxide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
L-Alaninamide, N-acetyl-L-tyrosyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-
3-O-(2-Methoxyethyl) 5-O-(3-phenylprop-2-enyl) 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
Tepotinib
cis-2,3-Dihydro-2-(4-alpha-L-rhamnopyranosyloxy-3-methoxyphenyl)-3-hydroxymethyl-7-hydroxy-5-benzofuranpropanol
Mortonol A
(+)-Isolariciresinol 2a-O-alpha-L-arabinopyranoside
4-{2-[[3-(4-hydroxy-3-methoxyphenyl)-2-propenyl]oxy]ethyl}-2-methoxyphenyl-beta-D-glucopyranoside
2,3-dihydro-7-methoxy-2-(4-hydroxy-3-methoxyphenyl)-3a-O-beta-D-xylopyranosyloxymethyl-5-benzofuranpropanol|9-O-beta-D-xylopyranoside vladinol F|dihydrodehydrodiconiferyl alcohol 9-O-beta-D-xylopyranoside
2,3-dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3a-alpha-L-rhamnopyranosyloxymethyl-5-benzofuranpropanol|Massonianoside A
(7S,8R)-3-demethoxydihydrodehydrodiconiferyl alcohol 4-O-beta-D-glucopyranoside|3-methoxyisocupressoside B
3-methoxy-3,4,9,9-tetrahydroxy-4,7-epoxy-5,8-lignan-3-O-alpha-L-rhamnopyranoside|juniperoside A
(7R,8S)-dihydrodehydrodiconiferyl alcohol 4-beta-D-xyloside
(8R)-isodehydrodiconiferyl alcohol-4-beta-D-xylopyranoside|acutumoside
2-{1-[(2R,3S)-2,3-dihydro-3-hydroxymethyl-5-(3-hydroxypropyl)-7-methoxy-2-benzofuranyl]-3,5-dimethoxy-4-phenoxy}-3-hydroxypropanoic acid methyl ester|dunnianeolignan A
13-O-beta-D-glucopyranosyl-gibberellin A5|GA5-13-O-glucoside
(5S)-1-((4-hydroxyphenyl)-7-(3,4-dihydroxyphenyl)-5-O-beta?D-glucopyranosyl)heptan-3-one
6-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl (2E)-3,7-dimethylocta-2,6-dienoate|jasminoside P
(2R*,3S*,4R*,6R*,7R*,8R*,10R*,11R*,14S*)-3-(2,3-epoxy-2-methylbutanoyloxy)-9-hydroxy-14-(3-hydroxy-3-methylbutanoyloxy)-14,15-epoxytrix-5(15)-en-4,12-olide
8-Ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate
GW 9578
Cilnidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Enalapril maleate
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-ethyl-4-[(Z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
C22H36O12_beta-D-Glucopyranose, 6-O-beta-D-glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]
(2R,3S,4S,5S,6R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]-6-methyloxane-3,4,5-triol
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate
[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 2,6,6-trimethylcyclohexene-1-carboxylate_major
(2R,3S,4S,5S,6R)-2-[4-[7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy]-6-methyloxane-3,4,5-triol_major
Ala Glu His His
Ala His Glu His
Ala His His Glu
Cys Asp Lys Gln
Cys Asp Gln Lys
Cys Glu Lys Asn
Cys Glu Asn Lys
Cys Gly Lys Trp
Cys Gly Trp Lys
Cys His His Pro
Cys His Pro His
Cys Lys Asp Gln
Cys Lys Glu Asn
Cys Lys Gly Trp
Cys Lys Asn Glu
Cys Lys Gln Asp
Cys Lys Trp Gly
Cys Asn Glu Lys
Cys Asn Lys Glu
Cys Asn Arg Thr
Cys Asn Thr Arg
Cys Pro His His
Cys Gln Asp Lys
Cys Gln Lys Asp
Cys Gln Arg Ser
Cys Gln Ser Arg
Cys Arg Asn Thr
Cys Arg Gln Ser
Cys Arg Ser Gln
Cys Arg Thr Asn
Cys Ser Gln Arg
Cys Ser Arg Gln
Cys Thr Asn Arg
Cys Thr Arg Asn
Cys Trp Gly Lys
Cys Trp Lys Gly
Asp Cys Lys Gln
Asp Cys Gln Lys
Asp Lys Cys Gln
Asp Lys Gln Cys
Asp Pro Val Tyr
Asp Pro Tyr Val
Asp Gln Cys Lys
Asp Gln Lys Cys
Asp Val Pro Tyr
Asp Val Tyr Pro
Asp Tyr Pro Val
Asp Tyr Val Pro
Glu Ala His His
Glu Cys Lys Asn
Glu Cys Asn Lys
Glu Phe Pro Thr
Glu Phe Thr Pro
Glu His Ala His
Glu His His Ala
Glu Ile Met Thr
Glu Ile Thr Met
Glu Lys Cys Asn
Glu Lys Asn Cys
Glu Leu Met Thr
Glu Leu Thr Met
Glu Met Ile Thr
Glu Met Leu Thr
Glu Met Thr Ile
Glu Met Thr Leu
Glu Asn Cys Lys
Glu Asn Lys Cys
Glu Pro Phe Thr
Glu Pro Thr Phe
Glu Thr Phe Pro
Glu Thr Ile Met
Glu Thr Leu Met
Glu Thr Met Ile
Glu Thr Met Leu
Glu Thr Pro Phe
Phe Glu Pro Thr
Phe Glu Thr Pro
Phe Pro Glu Thr
Phe Pro Thr Glu
Phe Thr Glu Pro
Phe Thr Pro Glu
Gly Cys Lys Trp
Gly Cys Trp Lys
Gly Lys Cys Trp
Gly Lys Trp Cys
Gly Trp Cys Lys
Gly Trp Lys Cys
His Ala Glu His
His Ala His Glu
His Cys His Pro
His Cys Pro His
His Glu Ala His
His Glu His Ala
His His Ala Glu
His His Cys Pro
His His Glu Ala
His His Pro Cys
His Pro Cys His
His Pro His Cys
His Ser Ser Tyr
His Ser Tyr Ser
His Tyr Ser Ser
Ile Glu Met Thr
Ile Glu Thr Met
Ile Met Glu Thr
Ile Met Thr Glu
Ile Thr Glu Met
Ile Thr Met Glu
Lys Cys Asp Gln
Lys Cys Glu Asn
Lys Cys Gly Trp
Lys Cys Asn Glu
Lys Cys Gln Asp
Lys Cys Trp Gly
Lys Asp Cys Gln
Lys Asp Gln Cys
Lys Glu Cys Asn
Lys Glu Asn Cys
Lys Gly Cys Trp
Lys Gly Trp Cys
Lys Asn Cys Glu
Lys Asn Glu Cys
Lys Gln Cys Asp
Lys Gln Asp Cys
Lys Trp Cys Gly
Lys Trp Gly Cys
Leu Glu Met Thr
Leu Glu Thr Met
Leu Met Glu Thr
Leu Met Thr Glu
Leu Thr Glu Met
Leu Thr Met Glu
Met Asp Val Glu
Met Glu Asp Val
Met Glu Ile Thr
Met Glu Leu Thr
Met Glu Thr Ile
Met Glu Thr Leu
Met Glu Val Asp
Met Ile Asp Asp
Met Ile Glu Thr
Met Ile Thr Glu
Met Leu Asp Asp
Met Leu Glu Thr
Met Leu Thr Glu
Met Asn Gln Thr
Met Asn Thr Gln
Met Gln Asn Thr
Met Gln Gln Ser
Met Gln Ser Gln
Met Gln Thr Asn
Met Ser Gln Gln
Met Thr Glu Ile
Met Thr Glu Leu
Met Thr Ile Glu
Met Thr Leu Glu
Met Thr Asn Gln
Met Thr Gln Asn
Met Val Asp Glu
Met Val Glu Asp
Asn Cys Glu Lys
Asn Cys Lys Glu
Asn Cys Arg Thr
Asn Cys Thr Arg
Asn Glu Cys Lys
Asn Glu Lys Cys
Asn Lys Cys Glu
Asn Lys Glu Cys
Asn Met Gln Thr
Asn Met Thr Gln
Asn Gln Met Thr
Asn Gln Thr Met
Asn Arg Cys Thr
Asn Arg Thr Cys
Asn Ser Ser Trp
Asn Ser Trp Ser
Asn Thr Cys Arg
Asn Thr Met Gln
Asn Thr Gln Met
Asn Thr Arg Cys
Asn Trp Ser Ser
Pro Cys His His
Pro Asp Val Tyr
Pro Asp Tyr Val
Pro Glu Phe Thr
Pro Glu Thr Phe
Pro Phe Glu Thr
Pro Phe Thr Glu
Pro His Cys His
Pro His His Cys
Pro Thr Glu Phe
Pro Thr Phe Glu
Pro Val Asp Tyr
Pro Val Tyr Asp
Pro Tyr Asp Val
Pro Tyr Val Asp
Gln Cys Asp Lys
Gln Cys Lys Asp
Gln Cys Arg Ser
Gln Cys Ser Arg
Gln Asp Cys Lys
Gln Asp Lys Cys
Gln Lys Cys Asp
Gln Lys Asp Cys
Gln Met Asn Thr
Gln Met Gln Ser
Gln Met Ser Gln
Gln Met Thr Asn
Gln Asn Met Thr
Gln Asn Thr Met
Gln Gln Met Ser
Gln Gln Ser Met
Gln Arg Cys Ser
Gln Arg Ser Cys
Gln Ser Cys Arg
Gln Ser Met Gln
Gln Ser Gln Met
Gln Ser Arg Cys
Gln Thr Met Asn
Gln Thr Asn Met
Arg Cys Asn Thr
Arg Cys Gln Ser
Arg Cys Ser Gln
Arg Cys Thr Asn
Arg Asn Cys Thr
Arg Asn Thr Cys
Arg Gln Cys Ser
Arg Gln Ser Cys
Arg Ser Cys Gln
Arg Ser Gln Cys
Arg Thr Cys Asn
Arg Thr Asn Cys
Ser Cys Gln Arg
Ser Cys Arg Gln
Ser His Ser Tyr
Ser His Tyr Ser
Ser Met Gln Gln
Ser Asn Ser Trp
Ser Asn Trp Ser
Ser Gln Cys Arg
Ser Gln Met Gln
Ser Gln Gln Met
Ser Gln Arg Cys
Ser Arg Cys Gln
Ser Arg Gln Cys
Ser Ser His Tyr
Ser Ser Asn Trp
Ser Ser Trp Asn
Ser Ser Tyr His
Ser Trp Asn Ser
Ser Trp Ser Asn
Ser Tyr His Ser
Ser Tyr Ser His
Thr Cys Asn Arg
Thr Cys Arg Asn
Thr Glu Phe Pro
Thr Glu Ile Met
Thr Glu Leu Met
Thr Glu Met Ile
Thr Glu Met Leu
Thr Glu Pro Phe
Thr Phe Glu Pro
Thr Phe Pro Glu
Thr Ile Glu Met
Thr Ile Met Glu
Thr Leu Glu Met
Thr Leu Met Glu
Thr Met Glu Ile
Thr Met Glu Leu
Thr Met Ile Glu
Thr Met Leu Glu
Thr Met Asn Gln
Thr Met Gln Asn
Thr Asn Cys Arg
Thr Asn Met Gln
Thr Asn Gln Met
Thr Asn Arg Cys
Thr Pro Glu Phe
Thr Pro Phe Glu
Thr Gln Met Asn
Thr Gln Asn Met
Thr Arg Cys Asn
Thr Arg Asn Cys
Val Asp Glu Met
Val Asp Met Glu
Val Asp Pro Tyr
Val Asp Tyr Pro
Val Glu Asp Met
Val Glu Met Asp
Val Met Asp Glu
Val Met Glu Asp
Val Pro Asp Tyr
Val Pro Tyr Asp
Val Tyr Asp Pro
Val Tyr Pro Asp
Trp Cys Gly Lys
Trp Cys Lys Gly
Trp Gly Cys Lys
Trp Gly Lys Cys
Trp Lys Cys Gly
Trp Lys Gly Cys
Trp Asn Ser Ser
Trp Ser Asn Ser
Trp Ser Ser Asn
Tyr Asp Pro Val
Tyr Asp Val Pro
Tyr His Ser Ser
Tyr Pro Asp Val
Tyr Pro Val Asp
Tyr Ser His Ser
Tyr Ser Ser His
Tyr Val Asp Pro
Tyr Val Pro Asp
N-Ac-Tyr-Val-Ala-Asp-CHO
Ac-YVAD-CHO (L-709049) is a potent, reversible, specific tetrapeptide interleukin-lβ converting enzyme (ICE) inhibitor with mouse and human Ki values of 3.0 and 0.76 nM. Ac-YVAD-CHO is also a caspase-1 inhibitor. Ac-YVAD-CHO can suppress the production of mature IL-lβ[1][2][3].
Isolariciresinol 9'-O-a-L-arabinofuranoside
6-O-?-D-Glucopyranosyl-1-O-[(2,6,6-trimethyl-1-cyclohexen-1-yl)carbonyl]-?-D-glucopyranose
[6-(2,6-dimethylnaphthalene-1-carbonyl)naphthalen-2-yl]-(2,6-dimethylnaphthalen-1-yl)methanone
2-(chloromethyl)oxirane,4-[2-(4-hydroxyphenyl)propan-2-yl]phenol,2-methylprop-2-enoic acid
tepotinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164000 - c-Met-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D000970 - Antineoplastic Agents
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-1-thio-b-D-glucopyranoside
(S)-1-((S)-2-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid compound with maleic acid (1:1)
2,2-[1,4-Phenylenebis(methyleneimino-4,1-phenyleneoxy)]bis[2-methylpropanoic acid]
[3-chloro-4-(4-pentylbenzoyl)oxyphenyl] 4-pentylbenzoate
4-Oxo-2-phenylmethanesulfonyl-octahydro-pyrrolo[1,2-A]pyrazine-6-carboxylic acid [1-(N-hydroxycarbamimidoyl)-piperidin-4-ylmethyl]-amide
loperamide
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78276 - Agent Affecting Digestive System or Metabolism > C266 - Antidiarrheal Agent D005765 - Gastrointestinal Agents > D000930 - Antidiarrheals
3-[[1-[[2-[[2-Acetamido-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid
3-O-(2-Methoxyethyl) 5-O-(3-phenylprop-2-enyl) 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
3-[1-azepanyl-[1-[(4-fluorophenyl)methyl]-5-tetrazolyl]methyl]-6,7-dimethoxy-1H-quinolin-2-one
5-[1-(2,5-dimethylphenyl)sulfonyl-4-piperidinyl]-3-[(4-methylphenyl)methyl]-2H-triazolo[4,5-d]pyrimidin-7-one
3-[[4-[[4-(2-methoxyphenyl)-1-piperazinyl]-oxomethyl]cyclohexyl]methyl]-2-sulfanylidene-1H-quinazolin-4-one
8-[[4-(5-Chloro-2-methylphenyl)-1-piperazinyl]methyl]-3-methyl-7-(2-phenylethyl)purine-2,6-dione
N-[(E)-[3-[[4-(4-fluorophenyl)piperazin-1-yl]methyl]-4-methoxyphenyl]methylideneamino]-4-hydroxy-3-methoxybenzamide
(4Z)-2,8:7,12:11,15:14,18:17,22-pentaanhydro-1,3-O-(2-carboxyethylidene)-4,5,6,9,10,13,19,20,21-nonadeoxy-L-arabino-L-allo-L-allo-docosa-4,9,20-trienitol
N-[(2R,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-2-(morpholine-4-carbonyl)-7-pyridin-3-yl-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2R,3R,3aS,9bS)-1-(cyclopentylmethyl)-3-(hydroxymethyl)-6-oxo-7-pyrimidin-5-yl-N-(1,3-thiazol-2-yl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
N-[(2S,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2R,3S)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-2-[4-morpholinyl(oxo)methyl]-7-(3-pyridinyl)-1-(3,3,3-trifluoropropyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(1S,9R,10R,11R)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-12-methyl-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
N-[(2R,3R)-4-[benzenesulfonyl-[(2S)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
N-[(2S,3R)-4-[benzenesulfonyl-[(2R)-1-hydroxypropan-2-yl]amino]-2-methoxy-3-methylbutyl]-N-methyl-1,3-benzodioxole-5-carboxamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[[3-(trifluoromethyl)phenyl]methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
(1R,9S,10S,11S)-10-(hydroxymethyl)-6-oxo-N-(4-phenylphenyl)-12-(pyridin-4-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-12-methyl-6-oxo-N-(2,2,2-trifluoroethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
9-(3,4-dimethoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-6,7,8a,9-tetrahydro-5H-[1,2,4]triazolo[5,1-b]quinazolin-8-one
2-Ethyl-4-[(z)-2-[(3-formamido-2-hydroxybenzoyl)amino]but-2-enoyl]oxy-3-(2-methylbutanoyloxy)pentanoic acid
(1r,3s,4s,5s,7r,8s)-7,8-dihydroxy-7-[(1s)-1-hydroxyethyl]-3-[(1e,3e,5e)-6-(4-methoxy-3-methyl-6-oxopyran-2-yl)hexa-1,3,5-trien-1-yl]-1,5-dimethyl-2,6-dioxabicyclo[3.2.1]octan-4-yl acetate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 2,6,6-trimethylcyclohex-1-ene-1-carboxylate
(2s,3s,4s,5s)-2-{[(2r,3r,4s)-6-hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methoxy}oxane-3,4,5-triol
(2s,3r,4r,5r,6s)-2-{4-[(2s,3r)-7-hydroxy-3-(hydroxymethyl)-5-(3-hydroxypropyl)-2,3-dihydro-1-benzofuran-2-yl]-2-methoxyphenoxy}-6-methyloxane-3,4,5-triol
5-(3-chloro-5-formyl-2,6-dihydroxy-4-methylphenyl)-3-methyl-1-(1,2,6-trimethyl-3-oxocyclohexyl)pent-3-en-2-yl butanoate
methyl (3as,4s,5s,11ar)-4-{[(2s)-2-hydroxy-2-methyl-3-oxobutanoyl]oxy}-10-methyl-3-methylidene-5-[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
2-(furan-3-yl)-6a,10b-dimethyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,4ah,5h,6h,7h,10ah-naphtho[2,1-c]pyran-4,10-dione
alboside iii
{"Ingredient_id": "HBIN015089","Ingredient_name": "alboside iii","Alias": "NA","Ingredient_formula": "C25H32O10","Ingredient_Smile": "CC1C(CC2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)OC(=O)C=CC4=CC=C(C=C4)OC)O","Ingredient_weight": "492.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "869","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "100982917","DrugBank_id": "NA"}